ASX - By Stock
|
IPD |
Re:
Ann: Appointment of CEO and CF&OO
|
|
Roger10
|
17 |
1.9K |
2 |
16:40 |
16:40 |
ASX - By Stock
|
17
|
1.9K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade
|
|
Roger10
|
51 |
19K |
1 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
51
|
19K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade
|
|
Roger10
|
51 |
19K |
4 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
51
|
19K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade
|
|
Roger10
|
51 |
19K |
16 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
51
|
19K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Roger10
|
60 |
18K |
4 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
60
|
18K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Supply agreement for Ac-225 with TerraPower Isotopes
|
|
Roger10
|
60 |
18K |
12 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
60
|
18K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Roger10
|
313 |
134K |
11 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
313
|
134K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Roger10
|
313 |
134K |
18 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
313
|
134K
|
18
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
1.1K
|
561K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
7 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
1.1K
|
561K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Roger10
|
595 |
211K |
8 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
595
|
211K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Roger10
|
313 |
134K |
9 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
313
|
134K
|
9
|
|
ASX - By Stock
|
TLX Biotech |
Re:
TLX v NEU
|
|
Roger10
|
10 |
3.6K |
6 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
10
|
3.6K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
3 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
190
|
64K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.1K
|
561K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
8 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.1K
|
561K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Elects to Withdraw from Proposed U.S. Listing
|
|
Roger10
|
116 |
45K |
8 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
116
|
45K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Seeks Trading Halt
|
|
Roger10
|
33 |
13K |
3 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
33
|
13K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Seeks Trading Halt
|
|
Roger10
|
33 |
13K |
6 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
33
|
13K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
Roger10
|
146 |
38K |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
146
|
38K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.1K
|
561K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
2 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.1K
|
561K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
4 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.1K
|
561K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Roger10
|
595 |
211K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
595
|
211K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Roger10
|
595 |
211K |
2 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
595
|
211K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
0 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
1.1K
|
561K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Aims Up To $4.17 Bln Valuation In US IPO
|
|
Roger10
|
112 |
45K |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
112
|
45K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Aims Up To $4.17 Bln Valuation In US IPO
|
|
Roger10
|
112 |
45K |
9 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
112
|
45K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
Roger10
|
146 |
38K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
146
|
38K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes TLX250-CDx (Zircaix) BLA Submission
|
|
Roger10
|
37 |
14K |
5 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
37
|
14K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes TLX250-CDx (Zircaix) BLA Submission
|
|
Roger10
|
37 |
14K |
4 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
37
|
14K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
190
|
64K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
190
|
64K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
10 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
190
|
64K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
64K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
64K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
64K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Roger10
|
190 |
64K |
10 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
64K
|
10
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
Roger10
|
1.0K |
399K |
15 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.0K
|
399K
|
15
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Response to ASX Query
|
|
Roger10
|
20 |
8.9K |
4 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
20
|
8.9K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Submits NDA for New Prostate Cancer Imaging Agent
|
|
Roger10
|
24 |
9.1K |
6 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
24
|
9.1K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
5 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
1.1K
|
561K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
1.1K |
561K |
3 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
1.1K
|
561K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
Roger10
|
40 |
12K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
12K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
Roger10
|
61 |
25K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
61
|
25K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix has Filed Registration Statement for Proposed US IPO
|
|
Roger10
|
43 |
13K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
43
|
13K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
Roger10
|
61 |
25K |
4 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
61
|
25K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
Roger10
|
61 |
25K |
6 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
61
|
25K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
Roger10
|
61 |
25K |
3 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
61
|
25K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
Roger10
|
61 |
25K |
1 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
61
|
25K
|
1
|
|